KLDO
PINK KALEIDO BIOSCIENCES$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001
- YTD change
- +0.00%
- vs 20-day SMA
- +5.21%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+0.00 (+0.00%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $0.2001
- KLDO is up 0% since the beginning of the year
- KLDO is up 0% over the past 12 months
- KLDO is up 0% over the past 1 month
- 0% of all KLDO investors are betting against KLDO
KLDO reads n/a: the 12-month move is +0.0%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.00%
- vs 8-day SMA
- +0.00%
No alerts for KLDO in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Kaleido Biosciences, Inc. is a clinical-stage healthcare company, which engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. The firm offers microbiome metabolic therapies (MMT), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan on January 27, 2015 and is headquartered in Lexington, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
